The world relies on Chinese medicines

The world relies on Chinese medicines
There is a consensus in the current pharmaceutical market that China has become the world's most important drug producer in recent years, and this conclusion is not reached casually, as many industry analysts and sources confirm that China is the world's leading supplier of APIs. Relevant research reports show that the WTO statistics from 2019 to the present years show that China's annual exports of pharmaceuticals have remained at about $40 billion, of which APIs account for 80%, and China and India have become the world's largest suppliers of APIs.
According to statistics, China and India as the world’s two giants of API suppliers gathered the world’s best quality API manufacture, they account for 70% of the total API shipped to the United States, accounting for 80% of the total API shipped to the EU. Many API or generic drugs from India have been analyzed for their basic ingredients from China, which leads to a surprising conclusion: Made in China has become the lifeblood of global medicine.

"Made in China" in the field of medicine
The national strategy “Made in China 2025” proposes to make the medical and biotechnology industries a national priority. The main reason why the local production of API in the rest of the world has been declining year after year since 2000 is due to the “Made in China 2025”strategy.
China-made medicine, whether they are API or generics, have become very popular in the global market thanks to the huge advantage of production cost. This huge cost advantage is due to China’s unique government advantage, Chinese API manufactures have access to a large number of government subsidies, and China also has the world’s largest industrial system, coupled with the national strategy to promote China’s pharmaceuticals has become the world’s largest supplier of pharmaceutical market.